Subscribe

Your FREE subscription will give you access to articles, research reports, Biopharma CEO Confidence quarterly reports and much more!

Precision Medicine & Diagnostics Practice

Understanding the Ecosystem for Precision Medicine & Diagnostics Companies

The diagnostics industry is growing in importance in the eyes of biopharmaceutical companies and healthcare providers. Initially, diagnostics were viewed as a way to diagnose disease. This has evolved to include companion diagnostic and personalized medicine opportunities that enhance our ability to predict disease and identify response in patients.

The Precision Medicine & Diagnostics Practice at Kineticos

The Precision Medicine & Diagnostics practice at Kineticos helps diagnostic companies—including labs and tools companies—maximize their commercial potential at the corporate and product levels while ensuring companies operate in an efficient manner.  Our team of industry experts has a technical and commercial understanding of diagnostic technologies such as molecular diagnostics, mass spectrometry, flow cytometry, immunoassay, multiplex technology, and next generation sequencing. This enables Kineticos to employ an innovative approach in each project.

The Precision Medicine & Diagnostics practice at Kineticos supports clients across three service areas including:

Corporate Strategy and Development

  • Market, Competitor, Customer Assessments
  • Go-to-Market Strategy
  • Licensing and Acquisitions

Technology and Innovation

  • Technology Assessment
  • R&D Innovation Strategy
  • Co-Development Models

Operational Excellence

  • Gap Analysis and Best Practice Implementation
  • Process Improvement
  • Post Merger Integration

Click the Tabs Below for Precision Medicine & Diagnostics Practice Case Studies, White Papers and Articles, and Blog

 

Case Studies
Articles
Blog
  • Go-to-Market Strategy and Tactical Deployment Plan

    Situation: A privately held emerging biotech company, with an innovative cancer detection test, retained Kineticos to assist them in effectively

     

    Read this Case Study

  • Business Planning and Launch

    Situation: An emerging concierge patient healthcare services company was nearing launch and requested that Kineticos support the final stages of

     

    Read this Case Study

  • Functional Process Improvement

    Situation: A leading global contract research organization dissatisfied with their lab’s scientific affairs function retained Kineticos to conduct an operational

     

    Read this Case Study

  • Lab Integration Strategy

    Situation: A global bioanalytical lab specializing in large-molecule bioanalysis was experiencing challenges while integrating with their large, geographically distant partner.

     

    Read this Case Study

  • Central Lab Operational Excellence

    Situation: A global contract research organization was experiencing operational challenges within the central lab causing the business unit to perform

     

    Read this Case Study

  • Oncology Pipeline Analysis

    Situation: An international company serving a variety of industries was seeking support in identifying potential checkpoint inhibitors for acquisition. Thus,

     

    Read this Case Study

  • Staying the Course

    Written by Mark Osterman, Senior Vice President, Kineticos Kineticos recently announced Q4 2015 results of the Biopharma CEO Confidence Index,

     

    Read this Article

  • Central Laboratories Holy Grail: Six Keys to Achieving Preferred Provider Status with BioPharmaceutical Companies

    Article Preview A critical growth driver for most any central laboratory
 is its ability to gain preferred provider agreements (PPAs):

     

    Read this Article

  • How Metrics Can Help Identify and Solve Operational Challenges

    Article Preview As the sophistication of operational practices across life sciences increases; unfortunately, so do the difficulty and complexity of

     

    Read this Blog Post

  • Growth by Acquisition in Life Sciences: Do You Have a Plan?

    Article Preview As the life sciences landscape continually changes, growth by acquisition has become increasingly common. Recent deals, such as

     

    Read this Blog Post

  • Next Generation Sequencing: Using Technology to Develop Mutually-Beneficial Partnerships

    Article Preview Arup Laboratories announced it will begin offering next-generation sequencing (NGS) based high resolution Human Leukocyte Antigen (HLA) genotyping

     

    Read this Blog Post

  • Role of Companion Diagnostics in Immuno-oncology Race Unfolding

    Article Preview Important oncology events, including ASCO and ESMO, have recently displayed the fruits of the huge investment drug companies

     

    Read this Blog Post

  • Merck KGaA Announces Acquisition of Sigma-Aldrich, Increasing Lab Supply Division Growth

    Article Preview Germany’s Merck KGaA has announced the acquisition of Sigma-Aldrich Corporation, a global life sciences tools (LST) firm, based

     

    Read this Blog Post

  • Outsourcing as Opportunity

    Article Preview An article published in FiercePharma discussed the top 10 largest pharma layoffs in 2013. Whenever layoffs are announced

     

    Read this Blog Post


Contact Us Today to Discover How We Can Elevate Your Business Our Strategy Consulting Services Are Designed to Enhance Your Value

Contact Us Today
Top